Publication Name	World Journal of Gastroenterology
Manuscript ID	2123
Country	Switzerland

Received	2013-01-30 09:28
Peer-Review Started	2013-01-30 15:19
To Make the First Decision	2013-03-04 11:58
Return for Revision	2013-03-18 08:47
Revised	2013-04-17 16:48
Second Decision	2013-05-09 12:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-05-10 10:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-08-01 16:50
Publish the Manuscript Online	2013-08-19 18:22

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Diagnostic accuracy of a new point-of-care screening assay for celiac disease
Manuscript Source	Invited Manuscript
All Author List	Faiza Benkebil, Christophe Combescure, Silvia I Anghel, Cécile Besson Duvanel and Michela G Schäppi
Funding Agency and Grant Number	Funding Agency Grant Number Swiss Celiac Association, Association Romande de Coeliakie ME 8309 (to Schäppi MG)
Corresponding Author	Michela G Schäppi, MD, PhD, Clinique des Grangettes 7, Chemin des Grangettes, 1224 Chêne-Bougeries, Switzerland. michela.tempia@grangettes.ch
Key Words	Celiac disease; Deamidated gliadin; Total immunoglobulin A; Screening; Point-of-care assay
Core Tip	The aim of the present study was to evaluate the clinical accuracy of a new point-of-care device that is based on deamidated gliadin peptides (DGP) for diagnosis of celiac disease (CD). One-hundred-and-twelve patients with clinical symptoms suggestive of CD and/or first-degree relatives of CD patients, and patients with confirmed CD on a gluten-free diet, were prospectively enrolled in the study. The actual CD diagnosis had been based on serum-positive immunoglobulin A anti-tissue transglutaminase results by enzyme-linked immunosorbent assay and on biopsy findings. Overall evaluation shows that the new DGP-based rapid point-of-care test is an excellent screening tool for high-risk populations.
Publish Date	2013-08-19 18:22
Citation	Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schäppi MG. Diagnostic accuracy of a new point-of-care screening assay for celiac disease. World J Gastroenterol 2013; 19(31): 5111-5117
URL	http://www.wjgnet.com/1007-9327/full/v19/i31/5111.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i31.5111

Full Article (PDF)	WJG-19-5111.pdf
Manuscript File	2123-Review.doc
Answering Reviewers	2123-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatician Review Report_CC.pdf
Copyright License Agreement	2123-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	comite ethique Coeliakie-2.pdf
Non-Native Speakers of English Editing Certificate	2123-Language certificate.pdf
Peer-review Report	2123-Peer reviews.pdf
Scientific Editor Work List	2123-Scientific editor work list.doc